118 related articles for article (PubMed ID: 10321723)
21. Cytolytic and cytostatic properties of an anti-human Fc gammaRI (CD64) x epidermal growth factor bispecific fusion protein.
Goldstein J; Graziano RF; Sundarapandiyan K; Somasundaram C; Deo YM
J Immunol; 1997 Jan; 158(2):872-9. PubMed ID: 8993006
[TBL] [Abstract][Full Text] [Related]
22. [Expression of epidermal growth factor-adenovirus E4orf4 fusion protein in tumor cells and its cytotoxicity].
Bu PL; Wang DM; Chen H; Huang BR
Ai Zheng; 2005 Jan; 24(1):33-9. PubMed ID: 15642197
[TBL] [Abstract][Full Text] [Related]
23. [Expression of synthetic human angiogenin gene in E. coli in cleaved beta-galactosidase-angiogenin protein].
Kovalenko SP; Lisnyak IA; Mertvetsov NP
Bioorg Khim; 1989 Apr; 15(4):492-8. PubMed ID: 2502122
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxicity of human RNase-based immunotoxins requires cytosolic access and resistance to ribonuclease inhibition.
Erickson HA; Jund MD; Pennell CA
Protein Eng Des Sel; 2006 Jan; 19(1):37-45. PubMed ID: 16243897
[TBL] [Abstract][Full Text] [Related]
25. Expression of Met-(-1) angiogenin in Escherichia coli: conversion to the authentic less than Glu-1 protein.
Shapiro R; Harper JW; Fox EA; Jansen HW; Hein F; Uhlmann E
Anal Biochem; 1988 Dec; 175(2):450-61. PubMed ID: 3071185
[TBL] [Abstract][Full Text] [Related]
26. The recombinant anti-EGF receptor immunotoxin 425(scFv)-ETA' suppresses growth of a highly metastatic pancreatic carcinoma cell line.
Bruell D; Stöcker M; Huhn M; Redding N; Küpper M; Schumacher P; Paetz A; Bruns CJ; Haisma HJ; Fischer R; Finnern R; Barth S
Int J Oncol; 2003 Oct; 23(4):1179-86. PubMed ID: 12964002
[TBL] [Abstract][Full Text] [Related]
27. Targeting polyIC to EGFR over-expressing cells using a dsRNA binding protein domain tethered to EGF.
Edinger N; Lebendiker M; Klein S; Zigler M; Langut Y; Levitzki A
PLoS One; 2016; 11(9):e0162321. PubMed ID: 27598772
[TBL] [Abstract][Full Text] [Related]
28. High-level expression of three members of the murine angiogenin family in Escherichia coli and purification of the recombinant proteins.
Holloway DE; Hares MC; Shapiro R; Subramanian V; Acharya KR
Protein Expr Purif; 2001 Jul; 22(2):307-17. PubMed ID: 11437607
[TBL] [Abstract][Full Text] [Related]
29. EGF-mCherry Fusion Protein Expressed in E. coli Shows Product Heterogeneity but a High Biological Activity.
Feiner RC; Pennè I; Müller B; Müller KM
Biochemistry; 2019 Feb; 58(8):1043-1047. PubMed ID: 30735360
[TBL] [Abstract][Full Text] [Related]
30. Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis.
Shapiro R; Vallee BL
Biochemistry; 1989 Sep; 28(18):7401-8. PubMed ID: 2479414
[TBL] [Abstract][Full Text] [Related]
31. [Expression of synthetic gene for human angiogenin in E. coli cells].
Nikonova AA; Seregin SV; Chikaev NA; Mishin VP; Babkina IN; Mertvetsov NP
Bioorg Khim; 1996 Dec; 22(12):891-3. PubMed ID: 9054338
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxicity of a recombinant fusion protein of adenovirus early region 4 open reading frame 4 (E4orf4) and human epidermal growth factor on p53-deficient tumor cells.
Wang DM; Zhou Y; Xie HJ; Ma XL; Wang X; Chen H; Huang BR
Anticancer Drugs; 2006 Jun; 17(5):527-37. PubMed ID: 16702809
[TBL] [Abstract][Full Text] [Related]
33. A putative angiogenin receptor in angiogenin-responsive human endothelial cells.
Hu GF; Riordan JF; Vallee BL
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2204-9. PubMed ID: 9122172
[TBL] [Abstract][Full Text] [Related]
34. The complete amino acid sequence of bovine milk angiogenin.
Maes P; Damart D; Rommens C; Montreuil J; Spik G; Tartar A
FEBS Lett; 1988 Dec; 241(1-2):41-5. PubMed ID: 3197838
[TBL] [Abstract][Full Text] [Related]
35. Expression of the hAng gene in Escherichia coli; isolation and characterization of human recombinant Ser-(-1) angiogenin.
Lapidus AL; Mochul'skii AV; Podkovyrov SM; Lebedeva MI; Antipin AA; Izotova LS; Zagnit'ko OP; Komolova GS; Klesov AA; Veiko VP
Biomed Sci; 1990; 1(6):597-604. PubMed ID: 2132944
[TBL] [Abstract][Full Text] [Related]
36. Immunosuppressive activity of angiogenin in comparison with bovine seminal ribonuclease and pancreatic ribonuclease.
Matousek J; Soucek J; Ríha J; Zankel TR; Benner SA
Comp Biochem Physiol B Biochem Mol Biol; 1995 Oct; 112(2):235-41. PubMed ID: 7584854
[TBL] [Abstract][Full Text] [Related]
37. Targeting of EGF-displayed protein nanoparticles with anticancer drugs.
Matsumoto R; Hara R; Andou T; Mie M; Kobatake E
J Biomed Mater Res B Appl Biomater; 2014 Nov; 102(8):1792-8. PubMed ID: 24700640
[TBL] [Abstract][Full Text] [Related]
38. Chemical synthesis of a gene coding for human angiogenin, its expression in Escherichia coli and conversion of the product into its active form.
Denèfle P; Kovarik S; Guitton JD; Cartwright T; Mayaux JF
Gene; 1987; 56(1):61-70. PubMed ID: 3315860
[TBL] [Abstract][Full Text] [Related]
39. [Gene cloning, expression and purification of fusion protein epidermal growth factor-linker-trichosanthin].
Li YM; Yang HW; Luo R
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):205-7. PubMed ID: 17355938
[TBL] [Abstract][Full Text] [Related]
40. Production of a human epidermal growth factor fusion protein and its degradation in rat gastrointestinal flushings.
Xian CJ; Upton Z; Goddard C; Shoubridge CA; McNeil KA; Wallace JC; Read LC; Francis GL
J Mol Endocrinol; 1996 Feb; 16(1):89-97. PubMed ID: 8672237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
